These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18991804)

  • 21. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level.
    Curnutte JT
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 2):S2-15. PubMed ID: 8500277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components.
    Condino-Neto A; Whitney C; Newburger PE
    J Immunol; 1998 Nov; 161(9):4960-7. PubMed ID: 9794432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a thermolabile component of the human neutrophil NADPH oxidase. A model for chronic granulomatous disease caused by deficiency of the p67-phox cytosolic component.
    Erickson RW; Malawista SE; Garrett MC; Van Blaricom G; Leto TL; Curnutte JT
    J Clin Invest; 1992 May; 89(5):1587-95. PubMed ID: 1314852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon.
    Gupta JW; Kubin M; Hartman L; Cassatella M; Trinchieri G
    Cancer Res; 1992 May; 52(9):2530-7. PubMed ID: 1568222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
    Kawai C; Yamauchi A; Kuribayashi F
    Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
    Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
    Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).
    Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Rawat A; Vignesh P; Madkaikar M; Stasia MJ; Bakri FG; de Boer M; Roesler J; Köker N; Köker MY; Jakobsen M; Bustamante J; Garcia-Morato MB; Shephard JLV; Cagdas D; Tezcan I; Sherkat R; Mortaz E; Fayezi A; Shahrooei M; Wolach B; Blancas-Galicia L; Kanegane H; Kawai T; Condino-Neto A; Vihinen M; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
    Blood Cells Mol Dis; 2021 Dec; 92():102596. PubMed ID: 34547651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components.
    Cassatella MA; Bazzoni F; Flynn RM; Dusi S; Trinchieri G; Rossi F
    J Biol Chem; 1990 Nov; 265(33):20241-6. PubMed ID: 2173701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.
    El Hawary R; Meshaal S; Deswarte C; Galal N; Abdelkawy M; Alkady R; Elaziz DA; Freiberger T; Ravcukova B; Litzman J; Bustamante J; Boutros J; Gaafar T; Elmarsafy A
    J Clin Immunol; 2016 Aug; 36(6):610-8. PubMed ID: 27222152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different unequal cross-over events between NCF1 and its pseudogenes in autosomal p47(phox)-deficient chronic granulomatous disease.
    Hayrapetyan A; Dencher PC; van Leeuwen K; de Boer M; Roos D
    Biochim Biophys Acta; 2013 Oct; 1832(10):1662-72. PubMed ID: 23688784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood.
    Gallin JI
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S100-5. PubMed ID: 1934607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.
    Kutukculer N; Aykut A; Karaca NE; Durmaz A; Aksu G; Genel F; Pariltay E; Cogulu Ö; Azarsız E
    Scand J Immunol; 2019 Feb; 89(2):e12737. PubMed ID: 30506560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.
    Nunoi H; Ishibashi F; Mizukami T; Hidaka F
    Jpn J Infect Dis; 2004 Oct; 57(5):S25-6. PubMed ID: 15507763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
    Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
    Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.
    Stasia MJ; Bordigoni P; Floret D; Brion JP; Bost-Bru C; Michel G; Gatel P; Durant-Vital D; Voelckel MA; Li XJ; Guillot M; Maquet E; Martel C; Morel F
    Hum Genet; 2005 Jan; 116(1-2):72-82. PubMed ID: 15538631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.
    Vergnaud S; Paclet MH; El Benna J; Pocidalo MA; Morel F
    Eur J Biochem; 2000 Feb; 267(4):1059-67. PubMed ID: 10672014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.